Intuitive Surgical Logs Higher Profit, Revenue in 2Q

Dow Jones
Jul 23, 2025
 

By Kelly Cloonan

 

Intuitive Surgical logged higher profit and revenue in its second quarter on spreading use and installation of its robotic surgery system.

The medical-technology company on Tuesday posted a profit of $658.4 million, or $1.81 a share, compared with $526.9 million, or $1.46 a share, a year earlier.

Adjusted earnings per share were $2.19, ahead of estimates of $1.93 a share according to analysts polled by FactSet.

Revenue rose 21% to $2.44 billion and topped the $2.35 billion expected by analysts.

The Sunnyvale, Calif. company said installed bases and procedure volume of its da Vinci surgical system continued to grow, up 14% and 17%, respectively, from the year-ago period. The system is used for procedures such as prostatectomies, cardiac-valve repair and renal and gynecologic procedures.

Intuitive now expects worldwide da Vinci procedures to increase by about 15.5% to 17% in 2025, slightly raising the lower end of its previous outlook for growth of 15% to 17%.

The company also narrowed its outlook for adjusted gross profit margin for the year, guiding for a range of 66% to 67% of revenue compared to its previous guidance of 65% to 66.5%. The range includes an estimated 1% impact from tariffs currently in place, the company said.

 

Write to Kelly Cloonan at kelly.cloonan@wsj.com

 

(END) Dow Jones Newswires

July 22, 2025 16:58 ET (20:58 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10